PharmaCielo Ltd. (TSXV:PCLO)
Canada · Delayed Price · Currency is CAD 0.0700
-0.0100 (-12.50%)
Feb 9, 2026, 3:35 PM EST
PharmaCielo Revenue
PharmaCielo had revenue of 322.54K CAD in the quarter ending June 30, 2025, with 34.24% growth. This brings the company's revenue in the last twelve months to 3.56M, up 257.81% year-over-year. In the year 2024, PharmaCielo had annual revenue of 3.48M with 125.70% growth.
Revenue (ttm)
3.56M
Revenue Growth
+257.81%
P/S Ratio
5.79
Revenue / Employee
n/a
Employees
n/a
Market Cap
13.16M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.48M | 1.94M | 125.70% |
| Dec 31, 2023 | 1.54M | -3.77M | -70.96% |
| Dec 31, 2022 | 5.31M | 3.36M | 172.93% |
| Dec 31, 2021 | 1.94M | -708.92K | -26.71% |
| Dec 31, 2020 | 2.65M | 1.87M | 237.26% |
| Dec 31, 2019 | 786.90K | - | - |
| Dec 31, 2018 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ayr Wellness | 650.97M |
| 1CM Inc. | 75.01M |
| Red White & Bloom Brands | 70.97M |
| Avant Brands | 37.49M |
| Simply Solventless Concentrates | 33.70M |
| Medicure | 26.21M |
| Avicanna | 25.50M |
| Crescita Therapeutics | 22.07M |